189 results on '"Silvestri, Gerard A"'
Search Results
2. Navigational Bronchoscopy versus Computed Tomography-guided Transthoracic Needle Biopsy for the Diagnosis of Indeterminate Lung Nodules: protocol and rationale for the VERITAS multicenter randomized trial
3. ENHANCED DETECTION OF EARLY-STAGE LUNG CANCER WITH AN ULTRASENSITIVE PLASMA-BASED METHYLATION ASSAY
4. COMPARISON OF A HIGH SPECIFICITY BLOOD-BASED BIOMARKER WITH PET/CT FOR IDENTIFYING MALIGNANT PULMONARY NODULES
5. PILOT DATA ON THE ADEQUACY FOR NEXT GENERATION SEQUENCING IN EBUS-TBNA SPECIMEN VS LIQUID BIOPSIES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
6. TWO BIRDS WITH ONE STONE: A CROSS-REGISTRY ANALYSIS OF WOMEN UNDERGOING LUNG CANCER AND BREAST CANCER SCREENING
7. SAFETY RESULTS FROM MULTI-CENTER OBSERVATIONAL REAL-WORLD ROBOTIC BRONCHOCOPY (TARGET) STUDY
8. PULMONOLOGISTS' ATTITUDES AND ROLE IN PRECISION MEDICINE BIOMARKER TESTING FOR NON-SMALL CELL LUNG CANCER
9. Impact of diabetes on lung cancer screening efficacy in the NLST.
10. Using a Blood Biomarker to Distinguish Benign From Malignant Pulmonary Nodules
11. ACR Appropriateness Criteria® Lung Cancer Screening: 2022 Update
12. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging
13. Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening
14. Why Are Women More Likely to Be Overdiagnosed With Lung Cancer?
15. Guided bronchoscopy for the evaluation of pulmonary lesions: An updated meta-analysis
16. Shared Decision-Making During a Lung Cancer Screening Visit
17. A DECADE LATER AND WE HAVE NOT IMPROVED OUR DIAGNOSTIC YIELD WITH GUIDED BRONCHOSCOPY FOR EVALUATION OF PULMONARY LESIONS: AN UPDATED META-ANALYSIS
18. Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years
19. Factors Associated With Lung Cancer Screening Adherence Among Patients With Negative Baseline CT Results in a Community Health Care Setting
20. Lung Cancer Screening Rates During the COVID-19 Pandemic
21. Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer
22. Executive Summary
23. Tobacco Treatment Specialist Training for Lung Cancer Screening Providers
24. Screening for Lung Cancer
25. Pretreatment Invasive Nodal Staging in Lung Cancer
26. SEDATION WITH IV REMIMAZOLAM PROVIDES RAPID ONSET, RECOVERY, AND DISCHARGE READINESS IN BRONCHOSCOPY PATIENTS: RESULTS FROM A RANDOMIZED CLINICAL TRIAL
27. Response
28. Response
29. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers
30. Incorporating Baseline Lung Function in Lung Cancer Screening
31. Assessment of Integrated Classifier’s Ability to Distinguish Benign From Malignant Lung Nodules
32. Robotic Bronchoscopy for Peripheral Pulmonary Lesions
33. Response
34. Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening
35. KNOWLEDGE AND PRACTICE PATTERNS AMONG PULMONOLOGISTS FOR MOLECULAR BIOMARKER TESTING IN ADVANCED NON-SMALL CELL LUNG CANCER
36. LUNG NODULE INTEGRATED CLASSIFIER BIOMARKER: FIRST DATA WITH REAL-WORLD CLINICAL USE
37. SARCOID-LIKE REACTION TO IMMUNOTHERAPY MIMICS PROGRESSIVE MALIGNANCY ON IMAGING
38. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project
39. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic
40. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic
41. An Evaluation of Diagnostic Yield From Bronchoscopy
42. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons
43. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial
44. UPDATED META-ANALYSIS OF GUIDED BRONCHOSCOPY FOR THE EVALUATION OF PULMONARY LESIONS
45. Commentary: Invasive mediastinal staging for lung cancer—Quality gap, evidence gap, both?
46. MULTICENTER, PROSPECTIVE PILOT AND FEASIBILITY STUDY OF ROBOTIC-ASSISTED BRONCHOSCOPY FOR PERIPHERAL PULMONARY LESIONS
47. Setting the Stage for Success in Lung Cancer
48. Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable
49. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy
50. Shared Decision-making and Lung Cancer Screening
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.